A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
The present protocol describes a mouse microsurgery infusion technique, which effectively delivers substances directly into the brain via the internal carotid artery.
Animal models of central nervous system (CNS) diseases and, consequently, blood-brain barrier disruption diseases, require the delivery of exogenous substances into the brain. These exogenous substances may induce injurious impact or constitute therapeutic strategy. The most common delivery methods of exogenous substances into the brain are based on systemic deliveries, such as subcutaneous or intravenous routes. Although commonly used, these approaches have several limitations, including low delivery efficacy into the brain. In contrast, surgical methods that locally deliver substances into the CNS are more specific and prevent the uptake of the exogenous substances by other organs. Several surgical methods for CNS delivery are available; however, they tend to be very traumatic. Here, we describe a mouse infusion microsurgery technique, which effectively delivers substances into the brain via the internal carotid artery, with minimal trauma and no interference with normal CNS functionality.
In vivo models of central nervous system (CNS) diseases require an effective delivery of exogenous substances, such as drugs, pathogens, or exosomes, into the brain. Therefore, an ideal delivery method should cause minimal trauma to the animal, preserve the integrity of the neuronal network, and achieve high substance concentrations in the brain 1.
Several surgical methods of local substance delivery have been described, including intra-sheath, intracerebral, and intraventricular injections or implants 2,3,4,5. These approaches, however, are considered traumatic to the CNS, and allow administration of only low volumes of the substance of interest. Moreover, it has been suggested that exogenous substances can be rapidly removed by the cerebrospinal fluid 6, and a low penetration range to the brain parenchyma has been observed 7 when the above-mentioned techniques are employed. Systemic delivery methods, such as oral, pulmonary, subcutaneous, and intravenous routes, are more commonly used in animal models, though they exhibit low effectiveness in delivering the substances to the CNS, due to uptake by other organs 8,9. Therefore, these routes of delivery require elevated doses of the administrated substances, increasing the risk of side effects and toxicity 10,11.
Here, we describe a mouse infusion microsurgery technique, which effectively delivers substances directly into the brain via the internal carotid artery. In addition to targeting the delivery to the CNS, this technique does not bypass normal physiological barriers and is therefore highly relevant to biological processes involved in the passages of therapeutics or pathogens into the brain.
The procedures involved in the following protocol have been approved by the University of Miami Institutional Animal Care and Use Committee (IACUC). In addition, all procedures are being conducted in facilities approved by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).
1. Preparation of Mice for Surgery
2. Dissection of the Common Carotid Artery (CCA)
3. Preparation of the CCA for Substance Infusion
4. Substance Infusion via ICA
5. Post Infusion Procedures
6. Incision Closing and Post-operative Care
The mouse infusion microsurgery technique described here is very versatile and has been used to deliver different substances directly into the brain, including the delivery of tumor cells in a representative model of brain metastasis formation 1,12.
This technique is also suitable to assess the pathological aspects of different pathogens in the CNS. In a mouse model of H...
The infusion microsurgery described here has been proved to be very successful in delivering exogenous substances of various biological features into the CNS, preventing unwanted dissemination throughout the body 1,12. Disruption of the blood-brain barrier is a pathological characteristic of several CNS-related diseases; therefore assessing the relationship of exogenous substances with the blood-brain barrier is of major importance and interest.
The authors have nothing to disclose.
We would like to thank Dr. Lei Chen (Icahn School of Medicine at Mount Sinai, NY) who first established the use of this model in our laboratory, and to Dr. Gretchen Wolff (German Cancer Research Center, Heidelberg, Germany) for disseminating the technique in our laboratory. Supported in part by HL126559, DA039576, MH098891, MH63022, MH072567, DA027569, and NSC 2015/17/B/NZ7/02985.
Name | Company | Catalog Number | Comments |
Anesthesia instrument | Vetequip | 901806 | |
Surgical scissors | Fine Science Tool | 14558-09 | |
Surgical forceps straight tip | Fine Science Tool | 00108-11 | |
Surgical forceps angled tip | Fine Science Tool | 00109-11 | |
Spring scissors | Fine Science Tool | 15000-08 | |
Nylon suture | Braintree Scientific | SUT-S 104 | |
Capillary tubing (Micro-Renathane 0.010” x 0.005” per ft.) | Braintree Scientific | MRE01050 | |
Closing suture | VWR | 95057-036 | |
Isoflurane | Piramal | ||
2,3,5-Triphenyltetrazolium chloride | FisherScientific | 50-121-8005 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved